Insulet opening

Discussion in 'Endocrinology' started by Insulet opening, Oct 2, 2018 at 12:29 AM.

Tags: Add Tags
  1. I see there is a lot of turn over here with this company. Anyone know why?
     

  2. anonymous

    anonymous Guest

    Not turnover, expansion.
     
  3. anonymous

    anonymous Guest

    high turnover, management is former Hologic people, 2 bad quarters you are done. competitor Tandem now has better product
     
  4. anonymous

    anonymous Guest

    It’s a little of both. Expanded 4x in 5 years. Also it’s a grind—weird mix between device and pharma with some DME mixed in. High growth expectations quarter over quarter.